.svg){kind=small}
Nov-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Amend Cannabis has shown fluctuating performance across different categories in the state of Missouri. In the Tincture & Sublingual category, Amend Cannabis held the 4th position in August 2024 but slipped to 5th place by September. Interestingly, the brand did not make it into the top 30 for October and November, indicating a significant drop in its market presence in this category. This decline could be attributed to increased competition or changes in consumer preferences, highlighting a potential area for strategic improvement.
In the Topical category, Amend Cannabis maintained a strong presence, although there was a gradual decline in rankings from 4th place in August to 6th in November 2024. Despite the drop in ranks, the brand consistently remained within the top 10, suggesting a stable, albeit slightly weakening, market position. The sales figures reflect this trend, with a noticeable decrease over the months, which could be indicative of seasonal changes or shifts in consumer demand. The ability to stay within the top 10 positions, however, shows resilience and a solid customer base that the brand can potentially leverage for future growth.
Competitive Landscape
In the Missouri topical cannabis market, Amend Cannabis has experienced a notable decline in its competitive positioning over the past few months. From August to November 2024, Amend Cannabis dropped from 4th to 6th place in rank, indicating a decrease in market share and competitive strength. This decline is particularly significant when compared to competitors like Heartland Labs, which maintained a strong position, consistently ranking between 3rd and 4th place, and Vlasic Labs, which improved its rank from 6th to 5th place in November. The sales trends reflect this shift, as Amend Cannabis saw a consistent decrease in sales from August to November, whereas Heartland Labs experienced a sales dip in November but maintained higher overall sales figures throughout the period. This competitive landscape suggests that Amend Cannabis may need to reassess its market strategies to regain its former standing and counteract the upward momentum of its rivals.
Notable Products
In November 2024, the top-performing product from Amend Cannabis was the CBD/THC 1:1 Transdermal Lotion (500mg CBD, 500mg THC) in the Topical category, which climbed to the number one rank from fourth place in October, with notable sales of 174 units. Following closely, the CBD/THC/CBC 1:1:1 Transdermal Lotion (500mg CBD, 500mg THC, 500mg CBC) secured the second rank, although its sales saw a significant drop from October's peak. The CBD/THC 1:1 Amend Infused Balm (250mg CBD, 250mg THC) and the CBD/THC 1:1 Amend Infused Balm (50mg CBD, 50mg THC) did not rank in November, indicating a shift in consumer preference. The CBD/THC 1:1 Amend Tincture (100mg CBD, 100mg THC, 30ml) also did not rank in November, after holding the second position in October. This shift highlights a dynamic change in product popularity, with topical products gaining traction over tinctures and balms.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
